Back to search
Meningococcal B Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Meningococcal B Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Meningococcal B Disease trials you may qualify forThe goal of this clinical trial is to evaluate the humoral immunogenicity of the meningococcal B vaccine (MenB-4C) in pediatric patients with autoimmune rheumat…
Sexual differences are a well-established source of biological variation in immune system functioning, with men often displaying lower adaptive immune responses…
This clinical trial is conducted in two parts. Part One employs a randomized, partially blinded, dose-escalation, partially active-controlled design. Part Two u…
Patients without a spleen (asplenia) experience an increased risk for septicaemia from encapsulated bacteria, which is associated with a high mortality rate. Me…
The bacterium (germ) Neisseria meningitidis causes meningitis and blood poisoning. N meningitidis is classified into different serogroups (types), based on its…
The main purpose of this study is to evaluate the immune response and safety of a booster dose of the meningococcal group B vaccine, rMenB+OMV NZ (also known as…